ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
12 Jun 2020 16:26

Takeda Offloads Asia-Focused Drugs to South Korea’s Celltrion

The Japanese drug maker, Takeda Pharmaceutical (4502 JP)  announced yesterday (11th June 2020) that it has entered into an agreement to divest a...

Share
07 Jun 2020 09:58

Asia Short Interest Weekly - Massive Short Increase on Meituan, Geely

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
325 Views
Share
27 May 2020 03:25

Celltrion H Block Deal: Terms, Overhang, Arb Yield, & Post-Deal Trade Angle

Terms & overhangHere is another deal by OEP on Celltrion Healthcare. 4M shares are on the table (2.64% of the SO). The seller set the discount...

Logo
317 Views
Share
09 May 2020 10:46

Asia Short Interest Weekly - Tencent, HSBC, Fast Retailing, Semco, Yageo

Starting this week, we will be publishing an Asian Short Interest weekly that looks at moves in market wide short interest and highlights moves in...

Logo
286 Views
Share
28 Apr 2020 18:00

Short Covering Tapers Off and Samsung Biologics Goes Up, Up and Away

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 24 April 2020, the...

Logo
282 Views
Share
x